Not applicableEnded earlyNCT00949052
What this trial is testing
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000